
Isaac Shomer
Examiner (ID: 12146, Phone: (571)270-7671 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 1343 |
| Issued Applications | 756 |
| Pending Applications | 157 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14273855
[patent_doc_number] => 20190134212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => SUPRAMOLECULAR PROTEIN ASSEMBLIES WITH ADVANCED FUNCTIONS AND SYNTHESIS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/146891
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16146891
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/146891 | Supramolecular protein assemblies with advanced functions and synthesis thereof | Sep 27, 2018 | Issued |
Array
(
[id] => 13867415
[patent_doc_number] => 20190030048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => CASEIN MICELLES FOR NANOENCAPSULATION OF HYDROPHOBIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/145286
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16145286
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/145286 | CASEIN MICELLES FOR NANOENCAPSULATION OF HYDROPHOBIC COMPOUNDS | Sep 27, 2018 | Abandoned |
Array
(
[id] => 16663805
[patent_doc_number] => 10933027
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-03-02
[patent_title] => Expanded pore particles and delivery methods thereof
[patent_app_type] => utility
[patent_app_number] => 16/141725
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 51
[patent_no_of_words] => 34997
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16141725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/141725 | Expanded pore particles and delivery methods thereof | Sep 24, 2018 | Issued |
Array
(
[id] => 16282697
[patent_doc_number] => 20200276299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => LIPOSOMAL FORMULATIONS COMPRISING SAPONIN AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/645456
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -74
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645456 | LIPOSOMAL FORMULATIONS COMPRISING SAPONIN AND METHODS OF USE | Sep 6, 2018 | Abandoned |
Array
(
[id] => 14273703
[patent_doc_number] => 20190134136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Pharmaceutical Composition on the Basis of Stachytarpheta SP., a Process for obtaining the same and its use for Treating Vitiligo
[patent_app_type] => utility
[patent_app_number] => 16/125034
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125034
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/125034 | Pharmaceutical Composition on the Basis of Stachytarpheta SP., a Process for obtaining the same and its use for Treating Vitiligo | Sep 6, 2018 | Abandoned |
Array
(
[id] => 16267187
[patent_doc_number] => 20200268674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => SYSTEM FOR DELIVERY OF MEDICAL COMPONENTS TO THE LUNGS
[patent_app_type] => utility
[patent_app_number] => 16/643682
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643682
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643682 | System for delivery of medical components to the lungs | Sep 4, 2018 | Issued |
Array
(
[id] => 18886455
[patent_doc_number] => 11865211
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Nanoparticle complex showing improved cellular uptake through surface modification using lipid and manufacturing method therefor
[patent_app_type] => utility
[patent_app_number] => 17/056402
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 5763
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056402 | Nanoparticle complex showing improved cellular uptake through surface modification using lipid and manufacturing method therefor | Sep 3, 2018 | Issued |
Array
(
[id] => 18603361
[patent_doc_number] => 11744801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Methods of making lipid nanoparticles
[patent_app_type] => utility
[patent_app_number] => 16/643037
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 89
[patent_no_of_words] => 50716
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643037
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643037 | Methods of making lipid nanoparticles | Aug 30, 2018 | Issued |
Array
(
[id] => 13986741
[patent_doc_number] => 20190062528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => COMPOSITIONS AND MEDICAL DEVICES COMPRISING ANTI-MICROBIAL PARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/117151
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16117151
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/117151 | COMPOSITIONS AND MEDICAL DEVICES COMPRISING ANTI-MICROBIAL PARTICLES | Aug 29, 2018 | Abandoned |
Array
(
[id] => 17133145
[patent_doc_number] => 11134676
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Anti-microbial particles and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/117693
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 20754
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16117693
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/117693 | Anti-microbial particles and methods of use thereof | Aug 29, 2018 | Issued |
Array
(
[id] => 17496406
[patent_doc_number] => 11285088
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Spherical silica particle size for RDA control
[patent_app_type] => utility
[patent_app_number] => 16/642069
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11907
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642069
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642069 | Spherical silica particle size for RDA control | Aug 27, 2018 | Issued |
Array
(
[id] => 13618369
[patent_doc_number] => 20180360736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => FILM DOSAGE FORM WITH EXTENDED RELEASE MUCOADHESIVE PARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/110737
[patent_app_country] => US
[patent_app_date] => 2018-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16110737
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/110737 | Film dosage form with extended release mucoadhesive particles | Aug 22, 2018 | Issued |
Array
(
[id] => 16450864
[patent_doc_number] => 20200360290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => ORAL COMPOSITIONS AND THE PREPARATION METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/638372
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638372 | Oral compositions and the preparation methods thereof | Aug 16, 2018 | Issued |
Array
(
[id] => 13603829
[patent_doc_number] => 20180353463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => Cannabinoid Formulations
[patent_app_type] => utility
[patent_app_number] => 15/998484
[patent_app_country] => US
[patent_app_date] => 2018-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15998484
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/998484 | Cannabinoid Formulations | Aug 15, 2018 | Abandoned |
Array
(
[id] => 16671298
[patent_doc_number] => 20210060061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => SELENIUM-DOPED BLACK PHOSPHORUS PRODRUG AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/643334
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643334
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643334 | SELENIUM-DOPED BLACK PHOSPHORUS PRODRUG AND PREPARATION METHOD THEREFOR | Aug 8, 2018 | Abandoned |
Array
(
[id] => 16482312
[patent_doc_number] => 20200375912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => LIPOSOMAL COATED NANOPARTICLES FOR IMMUNOTHERAPY APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/635246
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635246
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635246 | LIPOSOMAL COATED NANOPARTICLES FOR IMMUNOTHERAPY APPLICATIONS | Aug 2, 2018 | Abandoned |
Array
(
[id] => 13982155
[patent_doc_number] => 20190060235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => Pharmaceutical Formulations of PEGylated Liposomes and Blood Coagulation Factors
[patent_app_type] => utility
[patent_app_number] => 16/052300
[patent_app_country] => US
[patent_app_date] => 2018-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16052300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/052300 | Pharmaceutical formulations of PEGylated liposomes and blood coagulation factors | Jul 31, 2018 | Issued |
Array
(
[id] => 13574741
[patent_doc_number] => 20180338919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS
[patent_app_type] => utility
[patent_app_number] => 16/051728
[patent_app_country] => US
[patent_app_date] => 2018-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16051728
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/051728 | AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS | Jul 31, 2018 | Abandoned |
Array
(
[id] => 16718468
[patent_doc_number] => 20210085615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => BIOMOLECULAR COMPOSITES COMPRISING MODIFIED CELL GHOSTS
[patent_app_type] => utility
[patent_app_number] => 16/634651
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16634651
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/634651 | Biomolecular composites comprising modified cell ghosts | Jul 26, 2018 | Issued |
Array
(
[id] => 16482314
[patent_doc_number] => 20200375914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => BIODEGRADABLE MULTILAYER NANOCAPSULES FOR THE DELIVERY OF BIOLOGICALLY ACTIVE AGENTS IN TARGET CELLS
[patent_app_type] => utility
[patent_app_number] => 16/634060
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16634060
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/634060 | Biodegradable multilayer nanocapsules for the delivery of biologically active agents in target cells | Jul 24, 2018 | Issued |